Green Tea Anticancer Mechanisms in Smokers
1 other identifier
interventional
43
1 country
1
Brief Summary
The purpose of this study is to determine whether green tea may lower the risk of certain cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Jun 2010
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 23, 2010
CompletedFirst Posted
Study publicly available on registry
July 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedApril 21, 2015
April 1, 2015
3.2 years
June 23, 2010
April 20, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antioxidant effects of green tea versus placebo consumption.
Examine antioxidant effects of green tea versus placebo by measuring scavenging of free radicals; tea flavonoids; inflammatory cell secretion; endogenous antioxidant glutathione.
Measured at post treatment
Secondary Outcomes (1)
Non-antioxidant, cancer-relevant effects of green tea consumption
Measured at pre-treatment and post treatment
Study Arms (2)
Green Tea
EXPERIMENTAL4 cups daily of green tea for 6 weeks
No Green Tea
PLACEBO COMPARATOR4 cups daily of placebo tea for 6 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Healthy 23-40 year old males and non-pregnant females, who are moderately heavy smokers (1-1.75 packs/day, \> 2 years)
You may not qualify if:
- Habitual tea intake
- Habitual flavonoid supplementation
- Soy product intake over twice a week (soy is high in flavonoids).
- Pulmonary diseases
- Chronic or acute infection
- Admission of heavy alcohol intake (\> 14 beers or drinks a week)
- Body mass index (BMI) \> 30 (moderately overweight subjects will be taken)
- Abnormal EKG
- History of heart or other major health problems (ie arthritis, diabetes).
- Subjects with slightly high blood pressure will be eligible for the project, but more severe hypertension (\>150/100)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Philip Diazlead
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip Diaz, M.D.
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
June 23, 2010
First Posted
July 14, 2010
Study Start
June 1, 2010
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
April 21, 2015
Record last verified: 2015-04